Production (Stage)
CannaPharmaRX, Inc.
CPMD
$0.004
$0.000.00%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.20K | 2.20K | 7.00K | 9.10K | 12.10K |
Total Receivables | 284.40K | 20.50K | 270.60K | 270.20K | 85.20K |
Inventory | 951.10K | 996.30K | 1.22M | 1.24M | 950.20K |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 1.24M | 1.02M | 1.50M | 1.52M | 1.05M |
|
|||||
Total Current Assets | 1.24M | 1.02M | 1.50M | 1.52M | 1.05M |
Net Property, Plant & Equipment | 5.48M | 5.30M | 5.67M | 5.67M | 5.80M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 11.23M | 10.84M | 11.68M | 11.71M | 11.37M |
|
|||||
Total Accounts Payable | 5.07M | 4.78M | 7.89M | 5.11M | 8.29M |
Total Accrued Expenses | 7.36M | 2.50M | 1.85M | 1.43M | 807.70K |
Short-term Debt | 10.66M | 4.47M | 4.48M | 7.58M | 7.23M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.25M | 4.70M | 4.15M | 511.70K | 516.20K |
Total Finance Division Other Current Liabilities | 2.55M | 9.31M | 4.12M | 8.11M | 12.41M |
Total Other Current Liabilities | 2.55M | 9.31M | 4.12M | 8.11M | 12.41M |
Total Current Liabilities | 26.89M | 25.75M | 22.50M | 22.75M | 29.25M |
|
|||||
Total Current Liabilities | 26.89M | 25.75M | 22.50M | 22.75M | 29.25M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 10.66M | 4.47M | 4.48M | 7.58M | 7.23M |
Capital Leases | 4.85M | 4.89M | 5.76M | 5.63M | 5.64M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 31.74M | 30.65M | 28.27M | 28.38M | 34.90M |
|
|||||
Common Stock & APIC | 80.19M | 80.19M | 80.19M | 80.19M | 78.75M |
Retained Earnings | -101.87M | -101.18M | -97.44M | -97.63M | -102.99M |
Treasury Stock & Other | 549.40K | 556.20K | 40.50K | 144.90K | 86.30K |
Total Common Equity | -21.14M | -20.44M | -17.21M | -17.30M | -24.16M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 629.40K | 629.40K | 629.40K | 629.40K | 629.40K |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 629.40K | 629.40K | 629.40K | 629.40K | 629.40K |
|
|||||
Total Common Equity | -21.14M | -20.44M | -17.21M | -17.30M | -24.16M |
Total Preferred Equity | 629.40K | 629.40K | 629.40K | 629.40K | 629.40K |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -20.51M | -19.81M | -16.58M | -16.67M | -23.53M |
|